Brave Asset Management Inc Laboratory Corp Of America Holdings Transaction History

Brave Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$209.01 - $232.56 $8,778 - $9,767	-42 Reduced 4.05%	995 $217,000
Q4 2023 Jan 18, 2024	BUY	$197.69 - $227.29 $8,302 - $9,546	42 Added 4.22%	1,037 $235,000
Q3 2022 Oct 13, 2022	SELL	$204.81 - $262.19 $1,638 - $2,097	-8 Reduced 0.8%	995 $204,000
Q1 2022 Apr 22, 2022	SELL	$259.82 - $298.18 $3,117 - $3,578	-12 Reduced 1.18%	1,003 $264,000
Q4 2021 Jan 21, 2022	BUY	$271.6 - $314.21 $5,432 - $6,284	20 Added 2.01%	1,015 $319,000
Q2 2021 Jul 27, 2021	SELL	$251.87 - $278.14 $32,239 - $35,601	-128 Reduced 11.4%	995 $274,000
Q1 2021 Apr 26, 2021	SELL	$204.88 - $255.03 $28,683 - $35,704	-140 Reduced 11.08%	1,123 $286,000
Q4 2020 Jan 27, 2021	BUY	$186.91 - $214.42 $236,067 - $270,812	1,263 New	1,263 $257,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Brave Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Brave Asset Management Inc with notifications on news.